reposit
drug
use
antivir
treatment
critic
need
commonli
badli
perceiv
virologist
experienc
report
effect
azithromycin
zika
viru
respons
come
china
respiratori
diseas
caus
new
coronaviru
emerg
decemb
countri
inde
follow
recent
public
result
show
vitro
activ
chloroquin
data
report
efficaci
drug
patient
pneumonia
name
differ
level
sever
thu
follow
vitro
result
clinic
studi
launch
sever
chines
hospit
first
result
obtain
patient
show
superior
chloroquin
compar
treatment
control
group
term
reduct
exacerb
pneumonia
durat
symptom
delay
viral
clearanc
absenc
sever
side
effect
led
china
includ
chloroquin
recommend
regard
prevent
treatment
pneumonia
strong
ration
use
chloroquin
treat
infect
intracellular
microorgan
thu
malaria
treat
sever
decad
molecul
addit
team
use
hydroxychloroquin
first
time
intracellular
bacteri
infect
sinc
year
treat
intracellular
bacterium
coxiella
burnetii
agent
q
fever
shown
vitro
patient
compound
one
effici
kill
intracellular
pathogen
sinc
also
shown
activ
hydroxychloroquin
tropheryma
whipplei
agent
whippl
diseas
anoth
intracellular
bacterium
hydroxychloroquin
becom
refer
drug
altogeth
one
us
dr
treat
case
c
burnetii
whipplei
infect
year
person
data
regard
virus
reason
probabl
partli
ident
involv
alkalinis
chloroquin
phagolysosom
sever
studi
shown
effect
molecul
includ
coronavirus
among
sever
acut
respiratori
syndrom
sar
associ
coronaviru
tabl
previous
emphasis
interest
chloroquin
treatment
viral
infect
journal
predict
use
viral
infect
lack
drug
follow
discoveri
china
vitro
activ
chloroquin
discov
cultur
test
vero
cell
effect
concentr
ec
ec
valu
respect
antivir
activ
observ
addit
drug
carri
viral
infect
cell
await
great
interest
clinic
data
subsequ
vivo
data
commun
follow
first
result
clinic
trial
chines
team
also
arous
great
enthusiasm
among
us
show
chloroquin
could
reduc
length
hospit
stay
improv
evolut
pneumonia
lead
recommend
administr
mg
chloroquin
twice
day
patient
mild
moder
sever
form
pneumonia
dosag
therapeut
concentr
chloroquin
might
reach
experi
dosag
hydroxychloroquin
past
year
patient
longterm
treatment
year
know
dosag
mgday
reach
concentr
optim
dosag
issu
need
assess
come
day
us
activ
hydroxychloroquin
virus
probabl
chloroquin
sinc
mechan
action
two
molecul
ident
use
prescrib
long
period
hydroxychloroquin
would
therefor
first
choic
treatment
optim
treatment
may
necessari
administ
load
dose
follow
mainten
dose
